Hookipa Shares Rose Nearly 36% in Premarket Trading

Tiger Newspress2022-02-16

Hookipa shares rose nearly 36% in premarket trading.HOOKIPA Pharma Inc. , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced it has entered into an amended and restated collaboration and license agreement with Gilead to advance the development of a novel arenaviral immunotherapy as a component of a potential functional curative regimen for human immunodeficiency virus (HIV).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Handoko
    2022-02-16
    Handoko
    👌🏻
  • cwpang
    2022-02-16
    cwpang
    good
  • ShadowBan
    2022-02-16
    ShadowBan
    nice i don't know what share is this
  • Bubu11
    2022-02-16
    Bubu11
    Good 
  • Bubu11
    2022-02-16
    Bubu11
    Good
  • seetees
    2022-02-16
    seetees
    Like pls
Leave a comment
6